BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35414072)

  • 1. Integration of a community-based harm reduction program into a safety net hospital: a qualitative study.
    Khan GK; Harvey L; Johnson S; Long P; Kimmel S; Pierre C; Drainoni ML
    Harm Reduct J; 2022 Apr; 19(1):35. PubMed ID: 35414072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meeting people where they are: implementing hospital-based substance use harm reduction.
    Perera R; Stephan L; Appa A; Giuliano R; Hoffman R; Lum P; Martin M
    Harm Reduct J; 2022 Feb; 19(1):14. PubMed ID: 35139877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and Staff Perspectives on the Impacts and Challenges of Hospital-Based Harm Reduction.
    Fraimow-Wong L; Martín M; Thomas L; Giuliano R; Nguyen OK; Knight K; Suen LW
    JAMA Netw Open; 2024 Feb; 7(2):e240229. PubMed ID: 38386317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada.
    Russell C; Ali F; Nafeh F; LeBlanc S; Imtiaz S; Elton-Marshall T; Rehm J
    BMC Public Health; 2021 Nov; 21(1):2021. PubMed ID: 34742267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient perspectives on a harm reduction-oriented addiction medicine consultation team implemented in a large acute care hospital.
    Hyshka E; Morris H; Anderson-Baron J; Nixon L; Dong K; Salvalaggio G
    Drug Alcohol Depend; 2019 Nov; 204():107523. PubMed ID: 31541875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals.
    McNeil R; Kerr T; Pauly B; Wood E; Small W
    Addiction; 2016 Apr; 111(4):685-94. PubMed ID: 26498577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Barriers and Facilitators to Integrating a Harm Reduction Approach to Substance Use in Three Medical Settings.
    Lindenfeld Z; Hagan H; Chang JE
    J Gen Intern Med; 2023 Nov; 38(15):3273-3282. PubMed ID: 37227658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.
    Mansoor M; Foreman-Mackey A; Ivsins A; Bardwell G
    Harm Reduct J; 2023 Apr; 20(1):61. PubMed ID: 37118799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A home for body and soul: substance using women in recovery.
    Kruk E; Sandberg K
    Harm Reduct J; 2013 Dec; 10():39. PubMed ID: 24359089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. People with lived and living experience of methamphetamine use and admission to hospital: what harm reduction do they suggest needs to be addressed?
    Forchuk C; Serrato J; Scott L
    Health Promot Chronic Dis Prev Can; 2023 Jun; 43(6):338-347. PubMed ID: 37466399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences of stigma in hospitals with addiction consultation services: A qualitative analysis of patients' and hospital-based providers' perspectives.
    Hoover K; Lockhart S; Callister C; Holtrop JS; Calcaterra SL
    J Subst Abuse Treat; 2022 Jul; 138():108708. PubMed ID: 34991950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Taxonomy of Hospital-Based Addiction Care Models: a Scoping Review and Key Informant Interviews.
    Englander H; Jones A; Krawczyk N; Patten A; Roberts T; Korthuis PT; McNeely J
    J Gen Intern Med; 2022 Aug; 37(11):2821-2833. PubMed ID: 35534663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying barriers and facilitators for implementing harm reduction strategies for methamphetamine use into hospital settings.
    Forchuk C; Serrato J; Scott L
    Front Health Serv; 2023; 3():1113891. PubMed ID: 36926504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and facilitators to accessing inpatient and community substance use treatment and harm reduction services for people who use drugs in the Muslim communities: A systematic narrative review of studies on the experiences of people who receive services and service providers.
    Al-Ghafri Q; Radcliffe P; Gilchrist G
    Drug Alcohol Depend; 2023 Mar; 244():109790. PubMed ID: 36805826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "I wouldn't need Narcan for myself, but I can have it for somebody else:" perceptions of harm reduction among hospitalized patients with OUD.
    French R; Holliday Davis M; Aronowitz SV; Crowe M; Abrams M; Edwards G; Lowenstein M
    Addict Sci Clin Pract; 2023 Jun; 18(1):41. PubMed ID: 37355639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The integration of harm reduction services in the Veterans Health Administration (VHA): a qualitative analysis of barriers and facilitators.
    Harvey LH; Sliwinski SK; Flike K; Boudreau J; Gifford AL; Branch-Elliman W; Hyde J
    J Addict Dis; 2023 May; ():1-9. PubMed ID: 37154222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study.
    Hervera B; Seo G; Bartholomew TS; Chueng TA; Suarez E; Forrest DW; Hernandez S; Rodriguez AE; Tookes HE; Doblecki-Lewis S; Serota DP
    Addict Sci Clin Pract; 2023 Feb; 18(1):8. PubMed ID: 36747268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harm Reduction for Adolescents and Young Adults During the COVID-19 Pandemic: A Case Study of Community Care in Reach.
    Noyes E; Yeo E; Yerton M; Plakas I; Keyes S; Obando A; Gaeta JM; Taveras EM; Chatterjee A
    Public Health Rep; 2021 May; 136(3):301-308. PubMed ID: 33673755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
    Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
    Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.